Activity of Compound Agrimony Enteritis Capsules against invasive candidiasis: Exploring the differences between traditional Chinese medicine prescriptions and its main components in the treatment of diseases.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of ethnopharmacology"
DOI: 10.1016/j.jep.2021.114201
Abstract: ETHNOPHARMACOLOGICAL RELEVANCE Invasive candidiasis (IC) mainly occurs in patients who are immunocompromised or immunosuppressed; those who have undergone trauma, medical device implantation, organ transplantation; and patients with neutropenia. The mortality rate of IC is ∼40%,… read more here.
Keywords: invasive candidiasis; medicine; number; compound ... See more keywords
Candidemia and invasive candidiasis among hospitalized neonates and pediatric patients
Sign Up to like & getrecommendations! Published in 2017 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2017.1354824
Abstract: Abstract Objective: To investigate the epidemiology, treatment, length of stay (LOS) and costs for neonatal and pediatric inpatients with invasive candidiasis (IC). Methods: The Cerner Health Facts Database was used to assess inpatients (2005–2014) identified… read more here.
Keywords: invasive candidiasis; candidiasis; among hospitalized; candidemia invasive ... See more keywords
Reason and reality—identifying barriers to patient enrolment for clinical trials in invasive candidiasis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkac344
Abstract: Abstract Objectives Enrolment of subjects to clinical trials investigating novel drugs for infectious diseases is an ongoing challenge. In this study, we evaluate factors associated with non-enrolment in treatment trials for invasive candidiasis. Methods We… read more here.
Keywords: trials invasive; clinical trials; candidiasis; restore ... See more keywords
Factors determining the mortality in cirrhosis patients with invasive candidiasis: a systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Medical mycology"
DOI: 10.1093/mmy/myab069
Abstract: The impact of invasive candidiasis (IC) on the outcomes in the non-conventional high-risk cirrhosis population is poorly characterized. Therefore, we reviewed the outcomes and their influencing factors in cirrhosis patients with IC. PubMed, Embase, Ovid,… read more here.
Keywords: cirrhosis patients; invasive candidiasis; high mortality; cirrhosis ... See more keywords
Breakthrough Invasive Candidiasis in Children
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.024
Abstract: Abstract Background Breakthrough invasive candidiasis (bIC) has been described in adults, but the epidemiology and outcomes in children are unknown. Methods Retrospective cohort analysis of children diagnosed with IC from 9/1/09 to 1/30/17. bIC was… read more here.
Keywords: invasive candidiasis; breakthrough invasive; bic; epidemiology ... See more keywords
362. Species Distribution and Trends of Invasive Candidiasis in the United States, 2009–2015, Using a Large Electronic Medical Record Database
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.373
Abstract: Abstract Background While 50% of invasive candidiasis (IC) has historically been caused by C. albicans, the changing epidemiology and rise in drug-resistant Candida necessitates understanding the contribution of specific Candida species to IC. To date,… read more here.
Keywords: invasive candidiasis; record; blood; species distribution ... See more keywords
647: RISK FACTORS FOR INVASIVE CANDIDIASIS IN SURGICAL PATIENTS AFTER INTRA-ABDOMINAL PROCEDURES
Sign Up to like & getrecommendations! Published in 2019 at "Critical Care Medicine"
DOI: 10.1097/01.ccm.0000551399.08737.0e
Abstract: Learning Objectives: Previous studies have evaluated risk factors for invasive candidiasis (IC) in critically ill patients. However, risk factors have not been evaluated exclusively in critically ill patients after abdominal surgery, a population that could… read more here.
Keywords: invasive candidiasis; risk; risk factors; intra abdominal ... See more keywords
Rapid diagnosis of invasive candidiasis: ready for prime-time?
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Infectious Diseases"
DOI: 10.1097/qco.0000000000000594
Abstract: PURPOSE OF REVIEW We review the performance of culture-independent diagnostic tests (CIDTs), including β-D-glucan (BDG), polymerase chain reaction (PCR) and T2Candida, in diagnosing invasive candidiasis, their potential roles in patient management, and unintended consequences of… read more here.
Keywords: invasive candidiasis; t2candida; candidiasis; prime time ... See more keywords
Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis
Sign Up to like & getrecommendations! Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01113-22
Abstract: Candida bloodstream infections are associated with high attributable mortality, where early initiation of adequate antifungal therapy is important to increase survival in critically ill patients. The exposure variability of micafungin, a first-line agent used for… read more here.
Keywords: ill patients; critically ill; sampling strategies; invasive candidiasis ... See more keywords
Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis
Sign Up to like & getrecommendations! Published in 2017 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01398-17
Abstract: ABSTRACT The estimated attributable mortality rate for invasive candidiasis (IC) in the intensive care unit (ICU) setting varies from 30 to 40%. Physiological changes in critically ill patients may affect the distribution and elimination of… read more here.
Keywords: micafungin; invasive candidiasis; ill patients; liter ... See more keywords
Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model
Sign Up to like & getrecommendations! Published in 2018 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01572-18
Abstract: Rezafungin (CD101) is a novel echinocandin under development for once-weekly intravenous (i.v.) dosing. We evaluated the pharmacodynamics (PD) of rezafungin against 4 Candida auris strains, using the neutropenic mouse invasive candidiasis model. ABSTRACT Rezafungin (CD101)… read more here.
Keywords: invasive candidiasis; rezafungin; mouse invasive; candida auris ... See more keywords